Oxford Industries 99% Capital Cut Plan: Key Facts 2026

What the board approved on August 8, 2026

Oxford Industries Limited said its Board of Directors approved a proposal to reduce the company’s issued and paid-up equity share capital by 99%. The decision was taken at a board meeting held on August 8, 2026, at the company’s registered office in Mumbai. The company disclosed the outcome to BSE Limited under Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The company linked the move to accumulated business losses that stood at ₹12.9540 crore as of March 31, 2026. It also said the capital reduction is intended to clean up the balance sheet by setting off these losses against share capital. The proposal is not final yet and will require shareholder approval at the ensuing Annual General Meeting (AGM).

Size of losses and why the company wants a reset

Oxford Industries reported accumulated losses of ₹12.9540 crore as of March 31, 2026. The company framed the capital reduction as a balance sheet restructuring exercise, where losses are adjusted against capital rather than carried forward in the books. Such steps are typically pursued when historical losses have materially eroded net worth and management wants to present a clearer capital structure.

Alongside the longer-term accumulated losses, the board also approved the unaudited standalone financial results for the quarter ended June 30, 2026. For that quarter, the company reported a loss of ₹0.0345 crore.

What changes after a 99% paid-up capital reduction

As per the disclosure, the restructuring would leave the company with 59,360 fully paid-up equity shares of face value ₹10 each. The post-reduction paid-up capital would aggregate to ₹0.0594 crore.

The company positioned this as a “set-off” mechanism, using capital reduction to absorb past losses. However, the proposal remains subject to shareholder approval and applicable regulatory steps. The company also noted that filing the scheme with the stock exchange under Regulation 37 of SEBI (LODR) Regulations, 2015 may be required, if necessary.

Shareholder approval and Companies Act process

The company said shareholders must approve the scheme at the ensuing AGM. Separately, the context provided around the event also states that the capital reduction requires shareholder approval under Section 66 of the Companies Act, 2013.

For investors, the key point is that the board’s approval is only an initial step. The outcome will depend on member approval and completion of required filings and approvals under the applicable framework referenced in the disclosures.

Management changes: new promoter and CFO appointment

Oxford Industries also went through promoter and management changes in the same period. Mr. Saroj Kumar Choudhury emerged as the new promoter after an open offer, acquiring a 46.46% stake in the company. The data provided puts this holding at 2,761,576 shares, with the previous promoter, Mr. Mazher N Laila, exiting promoter control and being reclassified as a public shareholder.

The company also appointed Mr. Saroj Kumar Choudhury as Chief Financial Officer (CFO) effective July 17, 2026, as part of board decisions disclosed around that time. The same context also describes him as Managing Director (MD) alongside the promoter change.

Auditor change and other corporate proposals

The board accepted the resignation of the existing statutory auditor, M/s PAMS & Associates, and proposed the appointment of M/s Lipika and Associates as the new auditor for a five-year term, subject to member approval. These actions were disclosed as part of board outcomes around mid-July 2026.

In addition, the company proposed shifting its registered office from Maharashtra to Orissa, and amendments to the Memorandum and Articles of Association, pending shareholder approval.

Strategic pivot: textiles to healthcare and pharmaceuticals

Oxford Industries is classified under the Textiles - Weaving industry in the information provided. At the same time, the company indicated a strategic pivot by expanding its Main Object Clause to include healthcare and pharmaceutical activities. The stated scope includes hospitals, nursing homes, diagnostic centers, and pharmaceutical and chemical preparations.

This proposed diversification was disclosed alongside the management and capital restructuring actions. While the disclosures outline intent and approvals at the board level, any change in business scope would depend on completion of the required corporate approvals.

Key facts table

Market impact: what this signals for investors

A 99% capital reduction is a strong indicator that historical losses have been large relative to the company’s equity base. In practical terms, it is an accounting and capital-structure step to align stated capital with the company’s financial position as reflected by accumulated losses of ₹12.9540 crore.

The disclosed quarterly loss of ₹0.0345 crore for the quarter ended June 30, 2026 adds near-term context, indicating the company remained loss-making in that period. The combined set of actions, capital reduction, promoter change, CFO appointment, and auditor replacement, also highlights a phase of corporate reset, with multiple items pending shareholder approval.

Analysis: why the combination of actions matters

The capital reduction proposal, management transition, and business diversification plan are interconnected in how investors will evaluate governance and strategy. The promoter change, with Mr. Saroj Kumar Choudhury holding 46.46%, concentrates control and links future execution more directly to the new leadership team.

At the same time, the need for a steep capital reduction underscores financial stress from prior periods and the extent of value erosion referenced in the context provided. Any shift beyond textiles into healthcare and pharmaceuticals is a major change in stated business scope, and it will likely require careful monitoring through formal approvals and subsequent disclosures.

Conclusion

Oxford Industries has proposed a 99% reduction in paid-up share capital to set off accumulated losses of ₹12.9540 crore as of March 31, 2026, and it reported a quarterly loss of ₹0.0345 crore for the quarter ended June 30, 2026. The proposal is subject to shareholder approval at the ensuing AGM and any applicable SEBI (LODR) filings, including under Regulation 37 if required. The period has also been marked by a promoter transition, a CFO appointment effective July 17, 2026, and an auditor change that is subject to member approval. The next key checkpoint for shareholders will be the AGM decisions on the capital reduction and other pending proposals.